REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Xorix Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Xorix Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Xorix Sdn. Bhd is a pharmaceutical company that specializes in the design, construction, and commissioning of pharmaceutical manufacturing facilities. It operates within the pharmaceutical industry, focusing on galenical products and providing contract manufacturing services. Xorix offers research and development services for liquid-based dosage forms, including the creation of registration dossiers.

Headquarters
Lot 1,2,3 & 4, Kawasan Perindustrian Batu 7
Dungun; Terengganu; Postal Code: 23000

Contact Details: Purchase the Xorix Sdn. Bhd. report to view the information.

Website: http://www.xorix.com.my

Basic Information
Total Employees:
Purchase the Xorix Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Xorix Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Xorix Sdn. Bhd. report to view the information.
Incorporation Date:
July 13, 2004
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
42.47%
Purchase this report to view the information.
33.92%
Purchase this report to view the information.
16.96%
Purchase this report to view the information.
1%
Purchase this report to view the information.
1%
Subsidiaries
Pharma Pack Sdn. Bhd.
80%
Lembaga Kemajuan Perusahaan Pertanian Negeri Pahang
61%
Company Performance
Financial values in the chart are available after Xorix Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Net sales revenue
8.94%▲
Total operating revenue
8.94%▲
Operating Profit/Loss (EBIT)
15.97%▲
EBITDA
79.39%▲
Net Profit/Loss for the Period
-63.4%▼
Total Assets
-21.1%▼
Total Equity
-16.7%▼
Operating Profit Margin (ROS)
4.97%▲
Net Profit Margin
-10.85%▼
Return on Equity (ROE)
4.66%▲
Debt/Equity
11.16%▲
Quick Ratio
0%

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo